Insights On Upstream Manufacturing

  1. Label-Free Analysis Of Multiple Spheroids In A Matrix 11/7/2025

    Gain insight into how automated z-stack imaging and AI-based analysis enable accurate, label-free monitoring of spheroid development in 3D matrices for drug screening and cell culture workflows.

  2. Enhance Cell Line Development With Rapid Whole-Well Imaging 11/7/2025

    Whole-well imaging streamlines clone selection by enabling rapid, automated analysis of single-cell growth and morphology, which reduces manual effort and improves reproducibility.

  3. Automation-Assisted Washing Of Multicellular 3D Spheroids 11/7/2025

    Automated washing of 3D spheroids improves consistency, reduces cell loss, and streamlines staining workflows. See how this approach enhances reproducibility and throughput in microplate-based assays.

  4. What Researchers Should Look For When Choosing A CLD Partner 11/7/2025

    A strong track record in compliant saline production and scalable quality is key when selecting a biomanufacturing partner. See how these factors help ensure regulatory alignment and long-term success.

  5. Leveraging Single-Use Bioreactors In Bench-Scale Process Development 11/6/2025

    Scaling bioprocesses requires matching critical variables to ensure consistent cell behavior and product quality. Optimize operations with efficient tools that enable more experiments per year.

  6. Driving Biotherapeutic Innovation With Scalable Chromatography 11/6/2025

    Miniaturization and automation are solving critical chromatography bottlenecks. Learn how novel scalable tools accelerate resin screening and protein capture for both traditional and novel biotherapeutics.

  7. Megatrends For Bioproduction Media And Buffers 11/6/2025

    Customized formulations, rising costs, and stricter regulatory oversight are transforming bioproduction. Learn how emerging tools can help optimize efficiency, compliance, and cost-effectiveness in media and buffer manufacturing.

  8. Innovating Upstream AAV Manufacturing For The Next Wave Of Gene Therapies 11/6/2025

    High demand for AAV vectors requires overcoming current manufacturing challenges. Discover an optimized platform engineered to maximize AAV productivity, ensuring commercial readiness and faster speed to market.

  9. A Next-Generation CHO Host For High Producing Clones 11/6/2025

    Achieve superior titers without costly technology or new vectors. A production-adapted CHO host dramatically accelerates cell line development, reaching high yields in under 90 days.

  10. HEK293 Perfusion Strategy For Enhanced AAV And LV Production 11/6/2025

    Unlock higher AAV and LV yields with an intensified, cost-efficient perfusion strategy. Learn how a novel medium and tailored protocol support robust cell growth and superior viral vector productivity.